tm logo
GBT SOURCE
REGISTERED

on 12 Oct 2022

Last Applicant/ Owned by

GLOBAL BLOOD THERAPEUTICS INC.

181 Oyster Point BoulevardSouth San Francisco CA 94080

US

Serial Number

2046689 filed on 25th Feb 2020

Registration Number

TMA1145887 registered on 12th Oct 2022

Registration expiry Date

25th Feb 2030

Correspondent Address

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

GBT SOURCE

Trademark usage description

pharmacy referral services provided via a global computer network; specialized retail pharmacy referral services for patients with particular medical Read More

Classification Information


Class [035]
Pharmacy referral services provided via a global computer network; specialized retail pharmacy referral services for patients with particular medical conditions; promoting public awareness of the interests of sickle cell disease patients, all of the aforementioned services not for use in the dental field


Classification kind code

11

Class [036]
Prescription drug claims administration services, namely, healthcare insurance verification in the nature of insurance claim verification and payer reimbursement assessment and verification for prescription drugs; providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with information on available insurance benefits regarding pharmaceuticals, medical coverage, reimbursement options and financial support for that therapy; all of the aforementioned services not for use in the dental field.


Classification kind code

11

Class [044]
Providing medical information regarding sickle cell disease, therapeutic properties of pharmaceuticals, and medical treatment for sickle cell disease via a website and call center; providing health information relating to sickle cell disease and other chronic illnesses and their treatment; providing information relating to sickle cell disease and other chronic illnesses and their treatment, research relating to sickle cell disease and other chronic illnesses, pharmaceuticals for the treatment of sickle cell disease and other chronic illnesses via a website; medical services, namely, assisting in the monitoring, adherence and compliance of patients to medical treatments for sickle cell disease and other chronic illnesses, all of the aforementioned goods and services not for use in the dental field.


Classification kind code

11

Mark Details


Serial Number

2046689

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 231
on 19th May 2021
Limitation
Submitted for opposition 22
on 16th Apr 2021
Search Recorded
Submitted for opposition 20
on 16th Apr 2021
Examiner's First Report
Submitted for opposition 223
on 16th Apr 2021
Total Provisional Refusal
Submitted for opposition 135
on 03rd Mar 2021
Amendment to Application
Submitted for opposition 257
on 20th Aug 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 20th Aug 2020
Formalized
Submitted for opposition 1
on 20th Aug 2020
Created
Submitted for opposition 228
on 25th Feb 2020
International Registration
Submitted for opposition 30
on 25th Feb 2020
Filed